Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.22%||69.65||1.0%||$510.30m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.08%||205.22||1.9%||$451.66m|
|REGN||Regeneron Pharmaceuticals, Inc.||1.61%||635.09||2.7%||$406.05m|
|SNSS||Sunesis Pharmaceuticals, Inc.||2.38%||4.31||0.7%||$301.28m|
|EXAS||EXACT Sciences Corp.||3.12%||83.36||18.0%||$145.51m|
|BMRN||BioMarin Pharmaceutical, Inc.||2.23%||86.12||4.2%||$137.03m|
Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.